These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24964077)

  • 1. Time-dependent change of blood flow in the prostate treated with high-intensity focused ultrasound.
    Shoji S; Tonooka A; Hashimoto A; Nakamoto M; Tomonaga T; Nakano M; Sato H; Terachi T; Koike J; Uchida T
    Int J Urol; 2014 Sep; 21(9):942-5. PubMed ID: 24964077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological analysis of the effects of intraoperative transrectal compression of the prostate during high-intensity focused ultrasound for localized prostate cancer.
    Shoji S; Hashimoto A; Nakamoto M; Fukuda N; Fujikawa H; Endo K; Tomonaga T; Nakano M; Terachi T; Uchida T
    Int J Urol; 2015 Jun; 22(6):563-71. PubMed ID: 25808497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes.
    Shoji S; Nakano M; Fujikawa H; Endo K; Hashimoto A; Tomonaga T; Terachi T; Uchida T
    Int J Urol; 2015 Nov; 22(11):1043-9. PubMed ID: 26251127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
    Rouvière O; Glas L; Girouin N; Mège-Lechevallier F; Gelet A; Dantony E; Rabilloud M; Chapelon JY; Lyonnet D
    Radiology; 2011 May; 259(2):583-91. PubMed ID: 21357522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancer.
    Muto S; Kaminaga T; Horiuchi A; Kitamura K; Saito K; Isotani S; Yamaguchi R; Ide H; Furui S; Horie S
    Int J Urol; 2014 Aug; 21(8):776-80. PubMed ID: 24650235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience.
    Napoli A; Anzidei M; De Nunzio C; Cartocci G; Panebianco V; De Dominicis C; Catalano C; Petrucci F; Leonardo C
    Eur Urol; 2013 Feb; 63(2):395-8. PubMed ID: 23159454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.
    Ramsay E; Mougenot C; Staruch R; Boyes A; Kazem M; Bronskill M; Foster H; Sugar L; Haider M; Klotz L; Chopra R
    J Urol; 2017 Jan; 197(1):255-261. PubMed ID: 27545572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
    Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
    Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance image guided transurethral ultrasound prostate ablation: a preclinical safety and feasibility study with 28-day followup.
    Burtnyk M; Hill T; Cadieux-Pitre H; Welch I
    J Urol; 2015 May; 193(5):1669-75. PubMed ID: 25464003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate swelling and shift during high intensity focused ultrasound: implication for targeted focal therapy.
    Shoji S; Uchida T; Nakamoto M; Kim H; de Castro Abreu AL; Leslie S; Sato Y; Gill IS; Ukimura O
    J Urol; 2013 Oct; 190(4):1224-32. PubMed ID: 23583532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer.
    Lawrentschuk N; Finelli A; Van der Kwast TH; Ryan P; Bolton DM; Fleshner NE; Trachtenberg J; Klotz L; Robinette M; Woo H
    J Urol; 2011 Mar; 185(3):862-8. PubMed ID: 21239003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of contrast-enhanced transrectal ultrasound in predicting the nature of prostate diseases and the Gleason score of prostate cancer by a subjective blood flow grading scale.
    Zhao HW; Luo JH; Xu HX; Wang DH; Lai YR; Chen MN; Lv JY; Xie XY; Lu MD; Chen W
    Urol Int; 2011; 87(2):165-70. PubMed ID: 21832814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus.
    Zhang L; Chen WZ; Liu YJ; Hu X; Zhou K; Chen L; Peng S; Zhu H; Zou HL; Bai J; Wang ZB
    Eur J Radiol; 2010 Feb; 73(2):396-403. PubMed ID: 19108974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Magn Reson Imaging Clin N Am; 2015 Nov; 23(4):607-19. PubMed ID: 26499278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of contrast-enhanced ultrasonography in prostate cancer.
    Kundavaram CR; Halpern EJ; Trabulsi EJ
    Curr Opin Urol; 2012 Jul; 22(4):303-9. PubMed ID: 22617061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model.
    Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW
    Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.